These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27287466)

  • 21. In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
    Rosato A; Catalano A; Carocci A; Carrieri A; Carone A; Caggiano G; Franchini C; Corbo F; Montagna MT
    Bioorg Med Chem; 2016 Mar; 24(5):1002-5. PubMed ID: 26833243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on antifungal treatment of invasive Candida and Aspergillus infections.
    Maschmeyer G; Ruhnke M
    Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungals: what's in the pipeline.
    Tkacz JS; DiDomenico B
    Curr Opin Microbiol; 2001 Oct; 4(5):540-5. PubMed ID: 11587930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel strategies against Candida biofilms: interest of synthetic compounds.
    Girardot M; Imbert C
    Future Microbiol; 2016; 11(1):69-79. PubMed ID: 26673571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical mycology and antifungals in the pediatric population].
    Gonzalez G; Becerra A; Rodriguez Melo F; Campos T
    Drugs Today (Barc); 2008 Nov; 44 Suppl 4():7-21. PubMed ID: 19536370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
    Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
    Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination antifungal therapy for invasive fungal infections in children and adults.
    Hatipoglu N; Hatipoglu H
    Expert Rev Anti Infect Ther; 2013 May; 11(5):523-35. PubMed ID: 23627858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The echinocandins: three useful choices or three too many?
    Bal AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspofungin for the treatment of pediatric fungal infections.
    Fisher BT; Zaoutis T
    Pediatr Infect Dis J; 2008 Dec; 27(12):1099-102. PubMed ID: 19057369
    [No Abstract]   [Full Text] [Related]  

  • 34. Anidulafungin: when and how? The clinician's view.
    George J; Reboli AC
    Mycoses; 2012 Jan; 55(1):36-44. PubMed ID: 21668526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micafungin use in children.
    Emiroglu M
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antifungal activity and in vivo antibiofilm activity of cerium nitrate against Candida species.
    Silva-Dias A; Miranda IM; Branco J; Cobrado L; Monteiro-Soares M; Pina-Vaz C; Rodrigues AG
    J Antimicrob Chemother; 2015 Apr; 70(4):1083-93. PubMed ID: 25558078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida Biofilms: Development, Architecture, and Resistance.
    Chandra J; Mukherjee PK
    Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovations in the field of fungal biofilms: looking for new targets and new chemical compounds.
    Furlanetto C; Merluzzi S; Palcic S
    Infez Med; 2016 Sep; 24(3):183-9. PubMed ID: 27668897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms.
    Pierce CG; Srinivasan A; Ramasubramanian AK; López-Ribot JL
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.
    Choi HW; Shin JH; Jung SI; Park KH; Cho D; Kee SJ; Shin MG; Suh SP; Ryang DW
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1520-3. PubMed ID: 17283191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.